Document Details
Form
Filing Date
Sep 12, 2023
Document Date
Jun 30, 2023
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Altamira Therapeutics
Issuer
ALTAMIRA THERAPEUTICS LTD.
